Description
Tests for genetic polymorphisms associated with anticonvulsant drug sensitivity, particularly HLA-B1502, HLA-A3101, and CYP2C9 genes, used to assess risk of adverse drug reactions.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.